HOME >> BIOLOGY >> NEWS
Emory Researchers Advance Gene Therapy Studies For Metastatic Melanoma Treatment

generates enough GM-CSF to stimulate the mouse to mount a heightened immune response and destroy the tumor."

"In our studies, positioning the GM-CSF in direct contact with the melanoma cells could make a big difference," adds Ansel. "It may pack a much bigger punch than when it is coursing through the circulatory system."

Most clinical gene therapy for melanoma now being conducted around the country treats patients systemically, and results have not been particularly promising.

"We are experimenting not only with injecting the gene directly into the tumor," says Dr. Armstrong, "but also injecting the actual cytokine itself."

The presence of cytokines such as GM-CSF may eventually provide valuable prognostic indicators for melanoma that could improve treatment. The trick is to determine which cytokines actually combat tumor enlargement and which ones create a fertile environment in which the tumor fluorishes. The presence of certain cytokines may indicate that a tumor is indeed fast-growing, calling for a more aggressive therapy than might a more gradual growth.

For example, Drs. Ansel and Armstrong have recently completed a study using pathology archives to contrast the thickness of melanoma tumors. The researchers found that those tumors which produced GM-CSF were all thinner than those tumors which produced the cytokine IL8, which is known in many melanomas to be an autocrine growth factor.

Eventually Winship Cancer Center scientists plan to devise an entire menu of cytokine cell markers that would act as a road map for tumor behavior. They hope that the markers might also indicate how the tumors would react to different therapies. The significant number of studies currently underway throughout the country on cytokine markers makes this a realistic goal for the near future.

Drs. Ansel and Armstrong and their colleagues in Emory's Melanoma and Pigmented Lesion Center are developing a new
'"/>

Contact: Sarah Goodwin
sgoodwi@emory.edu
404-727-5686
Emory University Health Sciences Center
24-Apr-1997


Page: 1 2 3

Related biology news :

1. Emory researchers map structure of anti-cancer molecule
2. Hope Clinic of Emory Vaccine Center receives CDC contract
3. Emory scientists receive NIH MIDAS grant for computer modeling of infectious diseases
4. Emory researchers develop model to track the evolution of emerging infectious diseases
5. Emory scientists use enzymes to enhance regeneration of damaged peripheral nerves in mice
6. Emory scientists track down immune sentinel cells with gene gun
7. Emory researchers discover novel mechanism of how anthrax impairs immunity
8. Emory scientists find anti-tumor compounds in magnolia cones
9. Emorys CancerQuest wins top Web award from Scientific American
10. Emory University researchers uncover novel self-assembly of Alzheimers amyloid fibrils
11. Emory Vaccine Research Center study identifies specific gene required for long-term immunity

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: